4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-25-003519
Options or other derivatives
- Director acquired 20,491 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gupta Rishi · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-06 | Grant or award : show line 1 in the form Stock Option (right to buy) | +20,491 | 20,491 | D |
Loading xslF345X05/form4-02102025_100224.xml…